I missed out on these cheap shares last month, but I won’t in February!

This Fool didn’t buy these cheap shares in January and since then their prices have jumped. Here he details why he’s buying them now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young Asian man drinking coffee at home and looking at his phone

Image source: Getty Images

Who doesn’t love cheap shares? I plan to buy them today at a beaten-down rate and hopefully watch their share price grow as I hold them in my portfolio for the years to come.

That sounds ideal. It’s why I’m always on the lookout for the next stock to add to my holdings. To do that, I’m placing my focus on the UK.

Many shares have failed to recover from the volatility we’ve endured in the last few years. In fact, plenty have been struggling since 2016 following the Brexit vote. But not to worry. Instead, I’m dipping my toe into the market and snapping up bargains.

I missed out on these two last month. From their respective January lows, they’re both up over at least 4% as of today (7 February). I won’t be making the same mistake this month.

Blue Eagle Bank

I own Barclays (LSE: BARC) shares already. Yet with a price-to-earnings (P/E) ratio of 4.4, the fifth lowest on the FTSE 100, I plan to buy more.

Its share price dipped to 140.7p in January, meaning today’s price represents a 4.4% jump. I’m confident it’s got plenty of room left for growth.

I’m not expecting that any time soon, however. In the months to come, Barclays will face numerous headwinds. For example, high interest rates pose a threat to the bank as they lead to a greater likelihood of customers defaulting on payments.

But as we move towards the end of 2024 and the years to come, I think Barclays will shine. When interest rates fall, investor sentiment will rise.

A 5.3% dividend yield also makes Barclays a smart addition to my portfolio. With the income I receive, I’ll reinvest it back into buying more shares. At its current price, I think it’s too cheap to pass on.

Drinks behemoth

I’ve also been tracking drinks giant Diageo (LSE: DGE). Its share price has climbed 10.9% from its lowest point last month.

The company owns premium names including Guinness and Captain Morgan. However, its sales have been hit recently, especially in its Latin America and Caribbean (LAC) territory. For the six months to 31 December, sales fell by $310m in the region. This may be a theme that continues in the months to come as consumers look to cut back on spending.

However, I’m not too fussed. Instead, I think the firm’s presence in the LAC territory will pay dividends in the long term as disposable income levels and demand grow. The same can be said for regions such as Asia Pacific, where sales across the same period grew.

With a forward P/E ratio of 18.5, I also think the stock looks cheap. That’s below its historical average of the mid-20s.

Making a move

I’ll have some investible cash this month and I intend to use it to buy these two shares. Right now, I think they’re two of the biggest bargains on the FTSE 100. It’s cheap shares like these that I’m buying now to help build my wealth in the decades ahead.

Charlie Keough has positions in Barclays Plc. The Motley Fool UK has recommended Barclays Plc and Diageo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »